CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009)
SUZHOU, China, March 21, 2019 /PRNewswire/ — CStone Pharmaceuticals (“CStone”; HKEX: 2616) today announced that China’s National Medical Products Administration (NMPA) has approved the clinical trial application to begin a…
Sanofi Chief Executive Officer Olivier Brandicourt attended the China Development Forum and spoke at the Economic Summit
-Showing commitment to help promote the rapid implementation of rare diseases treatment in China BEIJING, March 24, 2019 /PRNewswire/ — Sanofi Chief Executive Officer Olivier Brandicourt expressed yesterday that he…
AAHRPP Accredits Three More Research Organizations
Two in the U.S., one in Taiwan attain the gold standard WASHINGTON, March 22, 2019 /PRNewswire/ — The Association for the Accreditation of Human Research Protection Programs today announced its…
Exyte demonstrates high-potential digital Smart Fab Solution at SEMICON China 2019
SHANGHAI, March 22, 2019 /PRNewswire/ — Exyte, the global leader in the design, engineering and construction of high-tech facilities, plants and factories, showcases its Smart Fab design concept at Semicon…
Equipping “Good Village Doctors” with AI technology
-Ping An Good Doctor Utilize Advanced Technology to Achieve Health and Poverty Alleviation BEIJING, March 21, 2019 /PRNewswire/ — The ceremony of “Village Warming with Blossom — Funding Presentation Ceremony…
Merck Opens First M Lab™ Collaboration Center in Europe
– Molsheim, France center supports pharmaceutical and biotechnology customers from pre-clinical through full-scale production in non-GMP environment – Hands-on customer access to Merck’s Life Science product portfolio and technical expertise…
Pharmaceutical Collaborations and Rare Diseases Drive the Drugs to Watch as New Blockbusters Are Forecast to Hit the Market in 2019
New report from Clarivate Analytics identifies seven new drugs predicted to achieve annual sales of >$1 billion by 2023 Game-changing therapies addressing immune-related and genetic disorders target under-served patient populations…
Concord Medical Announces New Appointments to Management Team
BEIJING, March 19, 2019 /PRNewswire/ — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a leading specialty hospital management solutions provider and an operator of the…
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD
– License and Collaboration Agreement was signed between OliX and Théa for OLX301A program, a novel treatment for dry and wet age-related macular degeneration.– OliX to receive an upfront payment…
CSPC Pharmaceutical Announces 2018 Annual Results
Profit Attributable To Shareholders Increased 31.9% to HK$3,655 Million Innovative Drug Business Continued to Deliver Strong Growth R&D Deployment Further Improved HONG KONG, March 18, 2019 /PRNewswire/ — CSPC Pharmaceutical…
